Flaherty J.D., Rossi J.S., Davidson C.J., et al. Coronary revascularization status and survival in acute heart failure: a report from the OPTIMIZE-HF registry. (abstr). Eur Heart J 28 Suppl (2007) 389-390
Clausell N., Behling A., Colombo F.C., et al. Effects of chronic use of sildenafil on exercise capacity and reactive pulmonary hypertension in patients with heart failure: a controlled clinical trial. (abstr). Eur Heart J 28 Suppl (2007) 387
Forster O., Hilfiker-Kleiner D., Ansari A.A., et al. The addition of bromocriptine to standard heart failure therapy improves outcome in peripartum cardiomyopathy. (abstr). Eur Heart J 28 Suppl (2007) 386-387
Dobson J., Pocock S., Granger C., et al. Weight loss is associated with increased mortality risk in patients with chronic heart failure: evidence from the CHARM program. (abstr). Eur Heart J 28 Suppl (2007) 270
Marcon P., D'aurizio F., Finato N., et al. Pluripotent stem cells obtained from failing heart are functionally impaired. (abstr). Eur Heart J 28 Suppl (2007) 786
Daemen J., Wenaweser P., Jüni P., Boersma E., Serruys P., and Windecker S. Late coronary stent thrombosis following drug-eluting stent implantation in routine clinical practice; 4-year follow-up of 8146 patients from Bern and Rotterdam. (abstr). Eur Heart J 28 Suppl (2007) 509
Vaquerizo B., Lefevre T., Garot P., et al. Long term predictors of death in patients treated by drug-eluting stents for unprotected left main lesions: insights from the French Left Main Taxus registry. (abstr). Eur Heart J 28 Suppl (2007) 136
Dirksen M.T., Suttorp M.J., Vink M.A., et al. No improvement of outcome and no increase in stent thrombosis 2 years after PCI with Paclitaxel-eluting Stents compared to uncoated stents for ST-segment Myocardial InfarctION: the PASSION trial. (abstr). Eur Heart J 28 Suppl (2007) 10
Ochala A., Wojakowski W., Smolka G., et al. Complete versus two-staged revascularization in patients with ST elevation myocardial infarction and multi-vessel coronary disease: final results of the prospective, randomized, multicenter trial. (abstr). Eur Heart J 28 Suppl (2007) 135-136
Ormiston J.A., Thuesen L., Dudek D., et al. Six-month angiographic and IVUS results of the first-in-man use of the Bioabsorbable Everolimus Eluting Coronary Stent System: the ABSORB trial. (abstr). Eur Heart J 28 Suppl (2007) 262
Devlin G., Swanson N., Silverstone A., et al. Do treatment delays influence outcomes following presentation with non-ST elevation acute coronary syndrome?. The GRACE registry. (abstr). Eur Heart J 28 Suppl (2007) 65
Jeong M.H., Gill G.C., Moon J.Y., et al. Clinical value of GRACE score in the prediction of mortality in patients with acute coronary syndrome. (abstr). Eur Heart J 28 Suppl (2007) 657
Kaski J.C., Fernandez-Berges D., Cruz Fernandez J.M., et al. A comparative study of multiple inflammatory markers for risk prediction in acute coronary syndrome. (abstr). Eur Heart J 28 Suppl (2007) 518
Dangas G., Manoukian S.V., Nikolsky E., et al. Baseline anemia is independently associated with early mortality in patients with ACS: results from the ACUITY trial. (abstr). Eur Heart J 28 Suppl (2007) 516
Bertrand M.E., Montalescot G., Collet J.P., Bassand J.P., and Yusuf S. Discontinuation of clopidogrel within the year following a non-ST-segment elevation acute coronary syndrome has a deleterious effect: evidence from the CURE trial. (abstr). Eur Heart J 28 Suppl (2007) 193
Gueret P., Blanchard D., Cambou J.P., et al. Major improvement in in-hospital and 6-month mortality after STEMI from 1995 to 2005 in relation to early management: results from the French USIK, USIC 2000 and FAST-MI registries. (abstr). Eur Heart J 28 Suppl (2007) 383
Tavares Aguiar C.M., and Ferreira J. Predictors of prehospital delay time in acute ST-elevation myocardial infarction. (abstr). Eur Heart J 28 Suppl (2007) 825
Zelizko M., Kala P., and Vojacek J. Predictors of death after primary PCI. Results of the Czech National PCI Registry. (abstr). Eur Heart J 28 Suppl (2007) 828
Danchin N., Belle L., Goldstein P., et al. Combined pre-hospital thrombolysis and high use of early PCI in STEMI patients is associated with mortality outcomes comparing favourably with those of primary PCI: data from the French FAST-MI register. (abstr). Eur Heart J 28 Suppl (2007) 571-572
Sanchez-Recalde A., Moreno R., Rivero F., et al. Impact of simple manual aspiration thrombectomy on myocardial perfusion in patients with ST-elevation myocardial infarction: a meta-analysis of seven randomized trials. (abstr). Eur Heart J 28 Suppl (2007) 59
Matteau A., Rinfret S., Dorais M., Lelorier J., and Reeves F. Safety and feasibility of immediately returning patients transferred for primary percutaneous coronary intervention in ST-elevation myocardial infarction. (abstr). Eur Heart J 28 Suppl (2007) 62
Abbate A., Biondi-Zoccai G.G.L., Appleton D.L., et al. Late percutaneous coronary intervention following acute myocardial infarction: a meta-analysis of the effects on cardiac function and remodeling. (abstr). Eur Heart J 28 Suppl (2007) 60
Gasior M., Gierlotka M., Witkowski A., et al. Elderly patients with acute myocardial infarction and cardiogenic shock on admission significantly benefit from invasive strategy. Results from PL-ACS registry. (abstr). Eur Heart J 28 Suppl (2007) 762
Fuhrmann J.T., Kolschmann S., Hirschmeyer J., Wunderlich C., Schoen S.P., and Strasser R.H. Hemodynamic effects of arginin-vasopressin in the occurrence of an inappropriate vasodilation complicating cardiogenic shock. (abstr). Eur Heart J 28 Suppl (2007) 762
Bohm K., Rosenqvist M., Herlitz J., and Svensson L. Is chest compression only as effective as standard treatment in out-of-hospital bystander cardiopulmonary resuscitation?. (abstr). Eur Heart J 28 Suppl (2007) 528
Wolfrum S., Pierau C., Radke P.W., Schunkert H., and Kurowski V. Hypothermia after cardiac arrest due to ST-elevation myocardial infarction (STEMI) in patients undergoing acute PCI. (abstr). Eur Heart J 28 Suppl (2007) 527
Reisinger J., Hoellinger K., Lang W., et al. Does early administration of selenium improve neurological outcome after cardiac arrest?. (abstr). Eur Heart J 28 Suppl (2007) 527-528
Kastelein J.J.P., Holme I., Faergeman O., et al. Lipid cut points below which lipids no longer predict residual risk. (abstr). Eur Heart J 28 Suppl (2007) 732
Pasterkamp G., Hellings W.E., De Kleijn D., De Vries J.P., de Bruin P., and Moll F. Local plaque characteristics are predictive for systemic cardiovascular events. Results from the ongoing Athero-Express study: a longitudinal study in 667 patients undergoing carotid endarterectomy. (abstr). Eur Heart J 28 Suppl (2007) 256
Jim M.H., Siu C.W., Ho H.H., et al. Transient atrial fibrillation complicating acute inferior myocardial infarction: implication on future risk for ischemic stroke. (abstr). Eur Heart J 28 Suppl (2007) 732
Lopes R.D., Mahaffey K.M., Harrington R.H., et al. Atrial fibrillation is associated with worse outcomes in ST elevation and non ST elevation acute coronary syndromes. (abstr). Eur Heart J 28 Suppl (2007) 259
Leclercq C., Rosier A., Crocq C., et al. Is baseline atrial rhythm a predictive factor of long term clinical response to cardiac resynchronisation therapy?. (abstr). Eur Heart J 28 Suppl (2007) 288
Kuniss M., Vogtmann T., Ventura R., et al. Comparison of radiofrequency ablation with cryoablation using a 8 mm tip ablation catheter for the ablation of common atrial flutter-a randomised study (CRYOTIP). (abstr). Eur Heart J 28 Suppl (2007) 159
Perings C., Bauer W., Bondke H., et al., RIONI Investigator Group. Automatic remote transmission of intracardiac electrograms after tachyarrhythmia detection enables improvements in ICD therapy. (abstr). Eur Heart J 28 Suppl (2007) 39
Speidl W.S., Ibanez B., Santos-Gallego C.G., et al. ApoAI-treatment rapidly increases aortic valve area in a hypercholesterolemic rabbit model. (abstr). Eur Heart J 28 Suppl (2007) 655
Richardson M., Marechaux S., Corseaux D., et al. Amlodipine improves aortic valve function in an experimental model of aortic valve sclerosis. (abstr). Eur Heart J 28 Suppl (2007) 654
Ngo D.T.M., Stafford I., Wuttke R.D., et al. Ramipril retards progression of aortic valve stenosis: association with preservation of nitric oxide effects. (abstr). Eur Heart J 28 Suppl (2007) 513
Chester A.H., Latif N., Sarathchandra P., et al. Beta 2-adrenergic receptor agonists inhibit osteoblastic differentiation of human aortic valve interstitial cells. (abstr). Eur Heart J 28 Suppl (2007) 652
Weidemann F., Herrmann S., Strotmann J.M., et al. Prognostic impact of functional and morphological changes in patients with severe aortic valve stenoses after valve replacement. (abstr). Eur Heart J 28 Suppl (2007) 117
Valencia Serrano F., Lopez Salazar B., Gomez Doblas J.J., et al. Non-invasive assessment of myocardial fibrosis in severe aortic stenosis patients. (abstr). Eur Heart J 28 Suppl (2007) 653
Monin J.L., Lim P., Monchi M., et al. Predictors of outcome in asymptomatic aortic stenosis: incremental value of B-type natriuretic peptide. (abstr). Eur Heart J 28 Suppl (2007) 512
Bergler-Klein J., Mundigler G., Pibarot P., et al. Is prognostic value of B-type natriuretic peptide superior to contractile reserve in low-flow aortic stenosis?. Results from the multicenter TOPAS study. (abstr). Eur Heart J 28 Suppl (2007) 513
Bonan R., Grube E., Laborde J.C., et al. Update experience with the percutaneous CoreValve aortic valve replacement in patients unsuitable for surgical aortic valve replacement. (abstr). Eur Heart J 28 Suppl (2007) 765
Messika-Zeitoun D., Harnek J., Buller C., et al. Preliminary results of the percutaneous MONARC system for the treatment of functional mitral regurgitation. (abstr). Eur Heart J 28 Suppl (2007) 765
Necas J., Kovalova S., and Vespalec J. Real-time 3D echocardiography: impact on quantification of mitral regurgitation by PISA method. (abstr). Eur Heart J 28 Suppl (2007) 395
Sugeng L., Shernan S.K., Shook D., Weinert L., Fox J., and Lang R.M. Real-time three-dimensional echocardiographic evaluation of cardiac anatomy: initial experience with a matrix transesophageal transducer. (abstr). Eur Heart J 28 Suppl (2007) 790
Lancellotti P., Radermecker M., Cosyns B., et al. Detection of latent left ventricular dysfunction in patients with organic mitral regurgitation by quantitative exercise 2-D speckle tracking echocardiography. (abstr). Eur Heart J 28 Suppl (2007) 395
Biagini E., Rocchi G., Lofiego C., et al. Left ventricular restrictive filling pattern in hypertrophic cardiomyopathy: prevalence, incidence, clinical/pathophysiological profile and prognostic implications. (abstr). Eur Heart J 28 Suppl (2007) 125-126
Gilard M., Le Gal G., Cornily J.C., et al. Prognosis of patients with suspected coronary artery disease and normal computed tomography. (abstr). Eur Heart J 28 Suppl (2007) 23
Dobrecky-Mery I., Gaspar T., Azencot M., et al. Prevalence of coronary artery disease demonstrated by 64-slice coronary CT angiography in asymptomatic patients with type 2 diabetes mellitus. (abstr). Eur Heart J 28 Suppl (2007) 23
Garlichs C.D., Yilmaz A., Frank T., et al. Evaluation of systemic inflammatory markers improves the prediction of coronary calcifications. (abstr). Eur Heart J 28 Suppl (2007) 107
Pundziute G., Schuijf J.D., Jukema J.W., et al. Plaque composition in stable coronary artery disease and acute coronary syndromes; systematic evaluation with multislice computed tomography and virtual histology intravascular ultrasound. (abstr). Eur Heart J 28 Suppl (2007) 658
Conradi G., Rixe J., Rolf A., Deetjen A., Hamm C.H.R., and Dill T. Radiation dose of the new dual source CT in multislice computed tomography of the coronaries. (abstr). Eur Heart J 28 Suppl (2007) 22
Kuhl H.P., Battenberg T., Heussen N., et al. Prognostic relevance of contrast-enhanced cardiovascular magnetic resonance in patients with severe ischemic cardiomyopathy. (abstr). Eur Heart J 28 Suppl (2007) 275
Husser O., Bodi Peris V., Sanchis J., et al. Diagnosis of multivessel disease and localization of coronary lesions using dipyridamole stress CMR in patients with chest pain. (abstr). Eur Heart J 28 Suppl (2007) 275
Hyafil F., Cornily J.C., Rudd J.H., et al. Quantification of macrophages in atherosclerotic plaques of rabbits using the novel specific CT contrast agent N1177: a comparison with PET-CT and histology. (abstr). Eur Heart J 28 Suppl (2007) 280
Doue T., Ohtsuki K., Hikosaka T., et al. The feasibility of Tc-99m annexin A5 to evaluate the anti-atherosclerotic therapy by HMG-CoA reductase inhibitor pravastatin in cholesterol-fed rabbits. (abstr). Eur Heart J 28 Suppl (2007) 793-794
Kraaijeveld A.O., Lucerna M.L., Van Oort R., et al. Myocyte enhancer binding factor 2 activity disruption induces phenotypic changes and signs of bleeding in atherosclerotic plaques. (abstr). Eur Heart J 28 Suppl (2007) 123
Donners M., and Waltenberger J. ADAM10: a novel metalloprotease interacting with the VEGF(R) pathway, expressed in human atherosclerosis and associated with plaque neovascularization. (abstr). Eur Heart J 28 Suppl (2007) 746
Dietrich T., Atrott K., Stawowy P., et al. Targeted immunocytokine therapy with interleukin-2 reduces plaque formation in aortic lesions from ApoE-deficient mice. (abstr). Eur Heart J 28 Suppl (2007) 746-747
Limbourg A., Ploom M., Elligsen D., Bahlmann F., Drexler H., and Limbourg F.P. Notch signaling regulates human endothelial progenitor cell differentiation and vascular repair via CXCR4. (abstr). Eur Heart J 28 Suppl (2007) 505
Wassmann S., Czech T., Werner N., and Nickenig G. Role of AT1a receptor expression on bone marrow-derived cells for the development of endothelial dysfunction and atherosclerosis. (abstr). Eur Heart J 28 Suppl (2007) 747
Stellos K., Langer H., Bigalke B., et al. Platelet-derived SDF-1 recruits and induces differentiation of human CD34+ progenitor cells to endothelial cells: implications in vascular and tissue regeneration. (abstr). Eur Heart J 28 Suppl (2007) 506
Segers V.F.M., Tokunou T., Macgillivray C., Gannon J., Higgins L.J., and Lee R.T. Intramyocardial delivery of protease-resistant stromal cell derived factor-1 by self-assembling peptide nanofibers. (abstr). Eur Heart J 28 Suppl (2007) 123
Ahmed M.S., Thomas Von L., Gravning J.A., Edvardsen T., and Smiseth O.A. Connective tissue growth factor inhibits myocardial growth, stimulates fibrosis, but preserves myocardial function in chronic pressure overload. (abstr). Eur Heart J 28 Suppl (2007) 7
Gravning J., Ahmed M.S., Martinov V., et al. Novel cardioprotective role of connective tissue growth factor in ischemia/reperfusion injury and heart failure. (abstr). Eur Heart J 28 Suppl (2007) 740
Ghaleh B., Souktani R., Pons S., et al. Inhibition of ischemia-induced cell death with the protein TAT-BIR3/RING extends the window for cardioprotection during reperfusion. (abstr). Eur Heart J 28 Suppl (2007) 741
Babiker F.A., Vanagt W.Y., Baynham T.C., Spinelli J., Delhaas T., and Prinzen F.W. Exploration of the mechanisms of pacing postconditioning. (abstr). Eur Heart J 28 Suppl (2007) 359-360
Sluijter J.P.G., Van Mil A., Korfage T.H., Metz C.H.G., Doevendans P.A.F.M., and Goumans M.J. MicroRNA-1 is involved in cardiomyocyte differentiation of human-derived cardiomyocyte progenitor cells. (abstr). Eur Heart J 28 Suppl (2007) 223
Van Vliet P., De Boer T.P., Sluijter J.P.G., Van Der Heyden M.A.G., Doevendans P.A., and Goumans M.J. Potassium inward rectifier expression is regulated by TGFbeta and BMP and increases during differentiation of cardiomyocyte progenitor cells. (abstr). Eur Heart J 28 Suppl (2007) 3